Table 1.
Clinical characteristics of subjects enrolled in the study. Data were collected at baseline (T0) and after 3 months (T1) and 6 months (T2) of treatment and are expressed as mean ± SD.
| ANOVA | t-Test | |||||
|---|---|---|---|---|---|---|
| T0 | T1 | T2 | F | p-Value | p-Value | |
| Sex (m/f) | 52/35 | |||||
| Age (yrs) | 58.3 ± 12.1 | |||||
| Height (cm) | 167.6 ± 8.5 | |||||
| Weight (kg) | 78.5 ± 15.9 | 76.3 ± 14.9 | <0.001 | |||
| BMI (kg/m2) | 27.8 ± 4.4 | 27.0 ± 4.2 | <0.001 | |||
| Total cholesterol (mg/dL) | 232.8 ± 21.3 | 203.2 ± 21.2 | 189 ± 19.4 | 91.99 | <0.001 | |
| HDL (mg/dL) | 50.6 ± 21.4 | 49.4 ± 8.7 | 50.8 ± 9.1 | 0.2 | 0.8 | |
| LDL (mg/dL) | 141.8 ± 37.3 | 123.1 ± 28.1 | 114 ± 27.5 | 15.83 | <0.001 | |
| Triglycerides (mg/dL) | 151.9 ± 37.3 | 128 ± 29.9 | 117.5 ± 23.9 | 25.1 | <0.001 | |
| Triglycerides/HDL | 3.3 ± 1.13 | 2.7 ± 0.9 | 2.4 ± 0.8 | 16.6 | <0.001 | |
| Total cholesterol/HDL | 5.0 ± 1.3 | 4.2 ± 0.9 | 3.9 ± 1.2 | 20.4 | <0.001 | |
| LDL/HDL | 3.1 ± 1.1 | 2.6 ± 0.8 | 2.3 ± 0.9 | 12.01 | <0.001 | |
| Glycaemia (mg/dL) | 108.3 ± 21.3 | 98.4 ± 18.6 | <0.001 | |||